dddd
PublishedNovember 17, 2025

Tuesday Markup of Litigation Funding Legislation

Although John Squires is busy destroying the PTAB—as of last week, he has now gone 0 for 34 on allowing institution of IPR petitions he reviews—the story in Congress is more positive. Tomorrow, the House Judiciary Committee is scheduled to mark up a number of bills. Most importantly, that list includes H.R. 2675, the Protecting Our Courts from Foreign Manipulation Act of 2025, and H.R. 1109, the Litigation Transparency Act of 2025.

Both of these bills aim to increase transparency into third-party litigation funding, a topic we’ve frequently discussed here on Patent Progress. The Litigation Transparency Act is quite simple—if there’s someone who stands to benefit from your litigation that isn’t a party, you have to tell the court and other litigants who it is and what the terms of the agreement between the parties are. This applies to all parties, not just patent owners, and to all forms of litigation, not just patent litigation. And fundamentally, it ensures that courts and parties can behave ethically—avoiding conflicts of interest and representing clients against clients. And it helps, though incompletely, make sure that litigation is driven to vindicate the interests of the plaintiff, not to provide windfall profits to private equity funders. Finally, it gives courts a window into whether the plaintiff is really the party in control – given the kinds of behavior some funders have engaged in with unsophisticated parties, this is likely quite necessary.

The Protecting Our Courts Act is more complex, but also narrower—it only impacts agreements with foreign entities. It requires disclosure of any agreements that create a right to financial benefit to any foreign person and specifically renders void any contract that obtains litigation funding from a foreign government or sovereign wealth fund. Both bills contain exceptions and definitions that ensure that impact and cause litigation, as well as ordinary contingency fee litigation, would not be impacted.

Litigation funding is already a huge problem, one that continues to grow. We hope that the House Judiciary Committee will report these bills out favorably—while neither would eliminate litigation funding in its entirety, both would help shine sunlight on the problem and limit some of the worst abuses.

Josh Landau

Patent Counsel, CCIA

Joshua Landau is the Patent Counsel at the Computer & Communications Industry Association (CCIA), where he represents and advises the association regarding patent issues.  Mr. Landau joined CCIA from WilmerHale in 2017, where he represented clients in patent litigation, counseling, and prosecution, including trials in both district courts and before the PTAB.

Prior to his time at WilmerHale, Mr. Landau was a Legal Fellow on Senator Al Franken’s Judiciary staff, focusing on privacy and technology issues.  Mr. Landau received his J.D. from Georgetown University Law Center and his B.S.E.E. from the University of Michigan.  Before law school, he spent several years as an automotive engineer, during which time he co-invented technology leading to U.S. Patent No. 6,934,140.

Follow @PatentJosh on Twitter.

More Posts

Step 1: Destroy IPR.  Step 2: ???  Step 3: Profit.

Last week, the USPTO issued a Notice of Proposed Rulemaking (NPRM) containing major changes to the institution process for inter partes review.  Combined with other changes made by the USPTO, inc...

Capable of Repetition, But Avoiding Review—USPTO New Regulation Not Reviewed By OIRA

The USPTO has put out a new NPRM, attempting to lock in place rules that were created without going through rulemaking in the prior Trump administration. While I have a lot to say about the substance...

John Squires Confirmed as USPTO Director, With Serious Work Ahead

Last Thursday, the Senate confirmed John Squires as Director of the U.S. Patent and Trademark Office (USPTO), advancing him alongside a slate of 47 other Trump Administration nominees in a single vote...

Subscribe to Patent Progress

No spam. Unsubscribe anytime.